
Zim Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-05-06 08:29:30Zim Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by improvements in technical indicators despite ongoing financial challenges. The pharmaceutical micro-cap’s Mojo Score rose to 36.0, reflecting a shift in market sentiment and technical trends, although fundamental weaknesses persist.
Read full news article
Zim Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-05 08:06:42Zim Laboratories Ltd has exhibited a notable shift in price momentum, reflecting a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways consolidation phase. Despite a robust 6.75% gain on 5 May 2026, the micro-cap pharmaceutical stock faces mixed signals from key technical parameters, warranting a nuanced analysis for investors navigating this evolving landscape.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-04-25 10:10:14Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 August 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis below presents the company’s current position as of 25 April 2026, incorporating the latest financial metrics, returns, and market data to provide investors with an up-to-date perspective.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-04-14 10:10:14Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-04-03 10:10:14Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd Falls to 52-Week Low of Rs 59.72 as Sell-Off Deepens
2026-03-30 15:16:50A sharp decline in Zim Laboratories Ltd saw the stock hit a fresh 52-week low of Rs 59.72 on 30 Mar 2026, marking a significant 53% drop from its 52-week high of Rs 126.95. This fall comes amid a broader market downturn, but the stock’s underperformance has been notably more severe, raising questions about the underlying factors driving this sell-off.
Read full news article
Zim Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens
2026-03-23 14:37:37A sharp decline of 8.16% today dragged Zim Laboratories Ltd to a fresh 52-week low of Rs 63, extending its downward trajectory amid broader market weakness and company-specific concerns.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-23 10:10:16Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-22 10:10:13Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Zim Laboratories Ltd has declared 5% dividend, ex-date: 19 Sep 19
No Splits history available
Zim Laboratories Ltd has announced 2:1 bonus issue, ex-date: 22 Dec 22
No Rights history available






